Synthesis, Calpain Inhibitory Activity, and Cytotoxicity of P2-Substituted Proline and Thiaproline Peptidyl Aldehydes and Peptidyl α-Ketoamides

Calpain is a cytosolic cysteine endopeptidase that has been implicated in a number of disorders including cancer. We have synthesized and studied the μ-calpain inhibitory activity and cytotoxicity of peptidyl aldehydes and peptidyl α-ketoamides with N-substituted d-proline or l-thiaproline residues...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 49; no. 17; pp. 5282 - 5290
Main Authors Korukonda, Rajani, Guan, Na, Dalton, James T, Liu, Jiuyu, Donkor, Isaac O
Format Journal Article
LanguageEnglish
Published Washington, DC American Chemical Society 24.08.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Calpain is a cytosolic cysteine endopeptidase that has been implicated in a number of disorders including cancer. We have synthesized and studied the μ-calpain inhibitory activity and cytotoxicity of peptidyl aldehydes and peptidyl α-ketoamides with N-substituted d-proline or l-thiaproline residues at the P2-postion. The most potent and most selective members of the series were (R)-1-(4-nitrophenylsulfonyl)-N-((R,S)-1-oxo-3-phenylpropan-2-yl)pyrrolidine-2-carboxamide (1j) and (R)-1-(4-iodophenylsulfonyl)-N-((R,S)-1-oxo-3-phenylpropan-2-yl)pyrrolidine-2-carboxamide (1n). The compounds inhibited μ-calpain with K i values of 0.02 μM and 0.03 μM, respectively, and displayed over 180-fold (1j) and 130-fold (1n) greater affinity for μ-calpain compared to cathepsin B. The cytotoxic effect of the compounds was evaluated in two leukemia cell lines (Daudi and Jurkat) and three solid tumor cell lines (DU-145, PC-3, and HeLa). Generally the compounds were modestly cytotoxic and displayed no correlation between the cytotoxic activity and μ-calpain inhibition.
Bibliography:ark:/67375/TPS-R7LRJV9J-5
istex:B6D7A765D9825AB05BA10826AE85F61C7261186F
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2623
1520-4804
DOI:10.1021/jm050849w